Zach Lomis

Gaingels is a leading venture investment syndicate in support of and representing the LGBTQIA+ community and allies in the venture capital space. Gaingels also supports its companies with a diverse talent and capital pipeline and provides an internal diverse board member recruitment advisory to help bring more diversity and representation within private boards. Gaingels invests in companies with diverse/LGBTQIA+ founders and C-suite leaders at all stages of growth, as well as in other high-growth companies resolved on building more inclusive teams. Gaingels is an ardent supporter the Diversity Term Sheet Rider Initiative to increase access to venture funding events for non-traditional check writers, and regularly co-invests with select VC leads across a variety of sectors, from technology, to B2B, healthcare and consumer, in competitive and over-subscribed rounds from Seed to Growth/pre-IPO. For more information visit www.gaingels.com.

We are a clinical stage company developing novel therapeutics inspired by kanna, or Sceletium tortuosum. Kanna is a medicinal succulent traditionally used by the San hunter-gatherers of South Africa.

Novamed is an investment firm that invests in, owns & operates several healthcare & real estate assets in emerging markets. We believe in driving the transformation of emerging market healthcare & real estate through collaboration, creative problem-solving & capital.

Novamed Ventures is a cross-border healthcare venture capital firm investing where need meets potential: high-opportunity emerging markets that are dramatically underfunded yet home to 5B+ people with limited access to quality care. We leverage our captive assets and worldwide network to aid our partner companies in building and de-risking scalable solutions that will transform healthcare.

Vantage manages a full-service clinical trials platform in Kazakhstan, partnering with biopharmaceutical organizations to provide advisory services facilitating the advancement of therapeutic or medical technology programs per unique benefits with their access to Kazakhstan’s healthcare administration and infrastructure.

Hidden Valley Ventures was founded by first-hand exposure to the key pain points plaguing our healthcare ecosystem, spurring my insatiable desire to dramatically innovate the way we handle mental health and addiction treatment. Motivated with the intent to facilitate the next wave of innovation, Ive dedicated the rest of my career to forging a new frontier with the most progressive, cutting-edge, and promising clinical research of our generation We back novel companies and unequivocal talent that tackle major disease burdens, creating both high impact and returns on a global basis.

Currently working on something new and very exciting